Comparison of long-term outcomes between peritoneal dialysis patients with diabetes as a primary renal disease or as a comorbid condition

PLoS ONE

Volumn 10, Issue 5, 2015, Pages

  Lei, Yutian ^a   Xiong, Yifan ^a   Zhang, Lin ^a   Yan, Hao ^a   Li, Zhenyuan ^a   Cao, Liou ^a   Huang, Jiaying ^a   Gu, Aiping ^a   Ni, Zhaohui ^a   Qian, Jiaqi ^a   Fang, Wei ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CHINA; COMORBIDITY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; FEMALE; FOLLOW UP; GLOMERULONEPHRITIS; HEMODIALYSIS; HUMAN; KIDNEY DISEASE; KIDNEY POLYCYSTIC DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEPHROSCLEROSIS; PERITONEAL DIALYSIS; PERITONITIS; PREDICTION; PROGNOSIS; SURVIVAL; ADVERSE EFFECTS; AGED; DIABETIC NEPHROPATHIES; KAPLAN MEIER METHOD; KIDNEY FAILURE, CHRONIC; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY;

AGED; DIABETIC NEPHROPATHIES; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PERITONEAL DIALYSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES;

EID: 84930637773     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0126549     Document Type: Article

References (22)

1. Sorensen VR, Mathiesen ER, Heaf J, Feldt-Rasmussen B. Improved survival rate in patients with diabetes and end-stage renal disease in Denmark. Diabetologia. 2007; 50(5):922-9. PMID: 17333109
2. Van Dijk PC, Jager KJ, Stengel B, Gronhagen-Riska C, Feest TG, Briggs JD. Renal replacement therapy for diabetic end-stage renal disease: data from 10 registries in Europe (1991-2000). Kidney Int. 2005; 67(4):1489-99. PMID: 15780102
3. Schwenger V, Mussig C, Hergesell O, Zeier M, Ritz E. Incidence and clinical characteristics of renal insufficiency in diabetic patients. Dtsch Med Wochenschr. 2001; 126(47):1322-6. PMID: 11719856
4. Schroijen MA, Dekkers OM, Grootendorst DC, Noordzij M, Romijn JA, Krediet RT, et al. Survival in dialysis patients is not different between patients with diabetes as primary renal disease and patients with diabetes as a co-morbid condition. BMC Nephrol. 2011; 12:69. doi: 10.1186/1471-2369-12-69 PMID: 22182634
5. Schroijen MA, van de Luijtgaarden MW, Noordzij M, Ravani P, Jarraya F, Collart F, et al. Survival in dialysis patients is different between patients with diabetes as primary renal disease and patients with diabetes as a co-morbid condition. Diabetologia. 2013; 56(9):1949-57. doi: 10.1007/s00125-013-2966-1 PMID: 23771173
6. Catalano C, Postorino M, Marino C. The impact of diabetes on patients' survival in dialysis patients with non-diabetic renal disease and in patients who develop diabetes during chronic dialysis. Nephrol Dial Transplant. 1996; 11(6):1124-8. PMID: 8671980
7. Davies SJ, Phillips L, Naish PF, Russell GI. Peritoneal glucose exposure and changes in membrane solute transport with time on peritoneal dialysis. J Am Soc Nephrol. 2001; 12(5):1046-51. PMID: 11316864
8. Bodnar DM, Busch S, Fuchs J, Piedmonte M, Schreiber M. Estimating glucose absorption in peritoneal dialysis using peritoneal equilibration tests. Adv Perit Dial. 1993; 9:114-8. PMID: 8105902
9. Perl J, Wald R, Bargman JM, Na Y, Jassal SV, Jain AK, et al. Changes in patient and technique survival over time among incident peritoneal dialysis patients in Canada. Clin J Am Soc Nephrol. 2012; 7 (7):1145-54. doi: 10.2215/CJN.01480212 PMID: 22554718
10. Armstrong VW, Creutzfeldt W, Ebert R, Fuchs C, Hilgers R, Scheler F. Effect of dialysate glucose load on plasma glucose and glucoregulatory hormones in CAPD patients. Nephron. 1985; 39(2):141-5. PMID: 3883205
11. Wener MH, Daum PR, McQuillan GM. The influence of age, sex, and race on the upper reference limit of serum C-reactive protein concentration. J Rheumatol. 2000; 27(10):2351-9. PMID: 11036829
12. Snaedal S, Heimburger O, Qureshi AR, Danielsson A, Wikstrom B, Fellstrom B, et al. Comorbidity and acute clinical events as determinants of C-reactive protein variation in hemodialysis patients: implications for patient survival. Am J Kidney Dis. 2009; 53(6):1024-33. doi: 10.1053/j.ajkd.2009.02.008 PMID: 19394732
13. Ducloux D, Bresson-Vautrin C, Kribs M, Abdelfatah A, Chalopin JM. C-reactive protein and cardiovascular disease in peritoneal dialysis patients. Kidney Int. 2002; 62(4):1417-22. PMID: 12234314
14. Wang AY, Woo J, Lam CW, Wang M, Sea MM, Lui SF, et al. Is a single time point C-reactive protein predictive of outcome in peritoneal dialysis patients? J Am Soc Nephrol. 2003; 14(7):1871-9. PMID: 12819248
15. Herzig KA, Purdie DM, Chang W, Brown AM, Hawley CM, Campbell SB, et al. Is C-reactive protein a useful predictor of outcome in peritoneal dialysis patients? J Am Soc Nephrol. 2001; 12(4):814-21. PMID: 11274243
16. Yeun JY, Kaysen GA. Acute phase proteins and peritoneal dialysate albumin loss are the main determinants of serum albumin in peritoneal dialysis patients. Am J Kidney Dis. 1997; 30(6):923-7. PMID: 9398142
17. Chung SH, Heimburger O, Stenvinkel P, Qureshi AR, Lindholm B. Association between residual renal function, inflammation and patient survival in new peritoneal dialysis patients. Nephrol Dial Transplant. 2003; 18(3):590-7. PMID: 12584284
18. Chung SH, Heimburger O, Stenvinkel P, Bergstrom J, Lindholm B. Association between inflammation and changes in residual renal function and peritoneal transport rate during the first year of dialysis. Nephrol Dial Transplant. 2001; 16(11):2240-5. PMID: 11682675
19. Moist LM, Port FK, Orzol SM, Young EW, Ostbye T, Wolfe RA, et al. Predictors of loss of residual renal function among new dialysis patients. J Am Soc Nephrol. 2000; 11(3):556-64. PMID: 10703680
20. Liao CT, Chen YM, Shiao CC, Hu FC, Huang JW, Kao TW, et al. Rate of decline of residual renal function is associated with all-cause mortality and technique failure in patients on long-term peritoneal dialysis. Nephrol Dial Transplant. 2009; 24(9):2909-14. doi: 10.1093/ndt/gfp056 PMID: 19225016
21. Chang YT, Wu JL, Hsu CC, Wang JD, Sung JM. Diabetes and end-stage renal disease synergistically contribute to increased incidence of cardiovascular events: a nationwide follow-up study during 1998-2009. Diabetes Care. 2014; 37(1):277-85. doi: 10.2337/dc13-0781 PMID: 23920086
22. Su YJ, Liao SC, Cheng BC, Hwang JC, Chen JB. Increasing high-sensitive C-reactive protein level predicts peritonitis risk in chronic peritoneal dialysis patients. BMC Nephrol. 2013; 14:185. doi: 10.1186/1471-2369-14-185 PMID: 24007461